Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates
See all the reports from ACC »REPORTS FROM ACC 17
Our experts analyse FOURIER and more...
17-19 March 2017

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Most viewed

From the Editors

FOURIER in the Hot Seat: What are the Implications for practice and accessFOURIER in the Hot Seat: What are the Implications for practice and access

Henry Ginsberg
John Chapman

FOURIER was a landmark trial for PCSK9 inhibition. However, a number of questions remain for clinical practice and access. PCSK9 Forum Co-Editors Profs John Chapman and Henry Ginsberg discuss these.

Watch the videos

Editor highlights of 2016 videos

Prof Tony Wierzbicki Benefit vs. cost of PCSK9 inhibitors
Prof Henry Ginsberg
Prof Tony Wierzbicki GLAGOV
Prof John Chapman
Prof Tony Wierzbicki PCSK9 inhibitors and diabetes risk
Prof Tony Wierzbicki
Prof Tony Wierzbicki Lipoprotein(a) in FH
Prof Derick Raal